Skip to main content
. 2022 Aug 30;14(17):4229. doi: 10.3390/cancers14174229

Figure 1.

Figure 1

Trial profile. (A), phase I; (B), phase IIa. * One patient showed a stable disease after completion of the phase 1 trial and enrolled in the phase 2a trial. AE, adverse event; SAE, serious adverse event.